Aura Biosciences, Inc.

NasdaqGM:AURA Stock Report

Market Cap: US$384.9m

Aura Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:AURA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
23 Jan 24SellUS$50,521Julie FederIndividual6,609US$7.64
23 Jan 24SellUS$121,141Elisabet de los PinosIndividual15,853US$7.64
09 Nov 23BuyUS$14,040,000Matrix Capital Management Company, LPCompany1,560,000US$9.00
08 Nov 23BuyUS$1,434,987David JohnsonIndividual199,601US$7.30
30 Oct 23SellUS$65,478Elisabet de los PinosIndividual9,586US$6.83
30 Oct 23SellUS$23,091Julie FederIndividual3,385US$6.82
04 Oct 23BuyUS$168,175David JohnsonIndividual20,066US$8.61

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of AURA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies4,2970.00868%
Individual Insiders721,3791.46%
VC/PE Firms3,039,8926.14%
General Public4,739,2119.57%
Hedge Funds14,779,16429.8%
Institutions26,249,07553%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 31%.


Top Shareholders

Top 25 shareholders own 85.13% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14%
Matrix Capital Management Company, LP
6,922,870US$53.8m29.1%0.44%
11.7%
Eventide Asset Management, LLC
5,802,682US$45.1m91.8%0.74%
8.53%
Adage Capital Management, L.P.
4,225,000US$32.8m47%0.06%
7.33%
Citadel Advisors LLC
3,631,294US$28.2m46.2%0.03%
6.14%
Medicxi Ventures (UK) LLP
3,039,892US$23.6m0%5.8%
4.24%
BlackRock, Inc.
2,098,745US$16.3m12.6%no data
4.09%
Advent Life Sciences LLP
2,023,857US$15.7m0%100.0%
4.07%
Lundbeckfonden BioCapital
2,017,652US$15.7m0%0.29%
3.49%
The Vanguard Group, Inc.
1,730,431US$13.4m67.8%no data
3.05%
Arix Bioscience plc
1,508,483US$11.7m0%100.0%
2.67%
Nantahala Capital Management, LLC
1,321,860US$10.3m77.7%0.95%
2.46%
Chiesi Ventures
1,218,803US$9.5m0%100.0%
2.09%
Goldman Sachs Group, Investment Banking and Securities Investments
1,037,299US$8.1m4.44%no data
1.42%
Regency Capital Management Inc.
704,974US$5.5m33.8%3.37%
1.37%
Geode Capital Management, LLC
676,128US$5.3m28.4%no data
1.33%
T. Rowe Price Group, Inc.
659,692US$5.1m0.41%no data
1.21%
Franklin Resources, Inc.
600,118US$4.7m0%no data
1.04%
Decheng Capital LLC
515,555US$4.0m-55.7%0.41%
1.02%
State Street Global Advisors, Inc.
506,262US$3.9m10.7%no data
0.86%
David Johnson
425,339US$3.3m48.9%no data
0.72%
Ensign Peak Advisors, Inc.
357,222US$2.8m0%0.01%
0.72%
FMR LLC
357,035US$2.8m-0.43%no data
0.69%
Long Focus Capital Management LLC
340,422US$2.6m74.4%0.32%
0.5%
Northern Trust Global Investments
248,431US$1.9m12.1%no data
0.4%
Monashee Investment Management, LLC
198,415US$1.5m0%0.25%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.